Antimycobacterials from natural sources: Ancient times, antibiotic era and novel scaffolds

Frontiers in Bioscience

Volumn 17, Issue 5, 2012, Pages 1861-1881

  Guzman, Juan D ^a,b   Gupta, Antima ^a   Bucar, Franz ^c   Gibbons, Simon ^b   Bhakta, Sanjib ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antibiotics; Antimycobacterials; MIC; Natural products; Review; SI; TB

Indexed keywords

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX; STREPTOMYCES;

TUBERCULOSTATIC AGENT;

CLASSIFICATION; DRUG DEVELOPMENT; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM; REVIEW;

ANTITUBERCULAR AGENTS; DRUG DISCOVERY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM;

EID: 84859259173     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4024     Document Type: Review

References (217)

1. J. Hayman: Mycobacterium ulcerans: an infection from Jurassic time? Lancet 324(8410), 1015-1016 (1984). (Pubitemid 14021715)
2. J. Hayman: A hypothesis refuted: Mycobacterium ulcerans is of recent evolution. Lancet Infect Dis 5(6), 327- 328 (2005). (Pubitemid 40779251)
3. B. M. Rothschild, L. D. Martin, G. Lev, H. Bercovier, G. Bar-Gal, C. Greenblatt, H. Donoghue, M. Spigelman and D. Brittain: Mycobacterium tuberculosis complex DNA from an extinct bison dated 17, 000 years before the present. Clin Infect Dis 33(3), 305-311 (2001). (Pubitemid 32664832)
4. W. L. Salo, A. C. Aufderheide, J. Buikstra and T. A. Holcomb: Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc Natl Acad Sci U S A 91(6), 2091-2094 (1994). (Pubitemid 24092048)
5. A. R. Zink, C. Sola, U. Reischl, W. Grabner, N. Rastogi, H. Wolf and A. G. Nerlich: Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J Clin Microbiol 41(1), 359- 367 (2003). (Pubitemid 36098600)
6. A. S. Weissfeld: Infectious diseases and famous people who succumbed to them. Clin Microbiol News 31(22), 169- 172 (2009).
7. J. Eisenstadt and G. S. Hall: Microbiology and classification of mycobacteria. Clin Dermatol 13(3), 197- 206 (1995).
8. N. Scherr and L. Nguyen: Mycobacterium versus Streptomyces-we are different, we are the same. Curr Opin Microbiol 12(6), 699-707 (2009).
9. V. Jarlier and H. Nikaido: Mycobacterial cell wall: Structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123(1-2), 11-18 (1994). (Pubitemid 24312557)
10. D. Thierry, M. D. Cave, K. D. Eisenach, J. T. Crawford, J. H. Bates, B. Gicquel and J. L. Guesdon: IS6110, an IS-like element of Mycobacterium tuberculosis complex. Nucl Acids Res 18(1), 188 (1990). (Pubitemid 20047834)
11. WHO: Global tuberculosis control. In: WHO report World Health Organization, (2010).
12. R. G. Neel, N. Paul, D. Keertan, H. S. Schaaf, Z. Matteo, S. Dick van, J. Paul and B. Jaime: Multidrugresistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375(9728), 1830-1843 (2010).
13. TAG: Report on tuberculosis research funding trends (2005-2008). In: Treatment Action Group, New York, USA, (2009).
14. M. Casenghi, S. T. Cole and C. F. Nathan: New approaches to filling the gap in tuberculosis drug discovery. PLoS Med 4(11), e293 (2007).
15. M. Zhenkun, L. Christian, M. Helen, J. N. Andrew and W. Xiexiu: Global tuberculosis drug development pipeline: the need and the reality. Lancet 375(9731), 2100-2109 (2010).
16. T. Wirth, F. Hildebrand, C. Allix-Béguec, F. Wölbeling, T. Kubica, K. Kremer, D. van Soolingen, S. Rüsch-Gerdes, C. Locht, S. Brisse, A. Meyer, P. Supply and S. Niemann: Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 4(9), e1000160 (2008).
17. T. M. Daniel: The history of tuberculosis. Respir Med 100(11), 1862-1870 (2006). (Pubitemid 44490295)
18. J. Koller, U. Baumer, Y. Kaup, M. Schmid and U. Weser: Effective mummification compounds used in pharaonic Egypt: Reactivity on bone alkaline phosphatase. Z Naturforsch 58(5), 462-480 (2003). (Pubitemid 36745421)
19. M. Christodoulaki, G. Moschaki, M. Kalloniatou, G. Tsoukalas, A. Kanitsakis, D. Athanasopoulos, S. Blazaki, S. Fiotaki and I. Tsoukalas: Tuberculosis according to Hippocrates. Paediatr Respir Rev 7, S294-S294 (2006).
20. J. M. Steger and T. L. Barret: Cutaneous tuberculosis. In: Military dermatology. Ed R. Zaijtchuk & R. F. Bellamy. Walter Reed Medical Army Center, Washington, USA, (1994).
21. S. Castaldo and F. Capasso: Propolis, an old remedy used in modern medicine. Fitoterapia 73, S1-S6 (2002). (Pubitemid 35472198)
22. Z. Yildirim, S. Hacievliyagil, N. O. Kutlu, N. E. Aydin, M. Kurkcuoglu, M. Iraz and R. Durmaz: Effect of water extract of Turkish propolis on tuberculosis infection in guinea-pigs. Pharmacol Res 49(3), 287-292 (2004). (Pubitemid 38064341)
23. R. S. Rivlin: Historical perspective on the use of garlic. J Nutr 131(3), 951S-954S (2001). (Pubitemid 32194987)
24. E. C. Delaha and V. F. Garagusi: Inhibition of mycobacteria by garlic extract (Allium sativum). Antimicrob Agents Chemother 27(4), 485-486 (1985). (Pubitemid 15097643)
25. J. E. Lancaster and H. A. Collin: Presence of alliinase in isolated vacuoles and of alkyl cysteine sulphoxides in the cytoplasm of bulbs of onion (Allium cepa). Pl Sci Lett 22(2), 169-176 (1981).
26. D. Lawson Larry: Garlic: A review of its medicinal effects and indicated active compounds. In: Phytomedicines of Europe. American Chemical Society, 14, 176-209 (1998).
27. P. Ratnakar and P. Murthy: Purification and mechanism of action of antitubercular principle from garlic (Allium sativum) active against isoniazid susceptible and resistant Mycobacterium tuberculosis H37Rv. Ind J Clin Biochem 10(1), 34-38 (1995).
28. R. S. Feldberg, S. C. Chang, A. N. Kotik, M. Nadler, Z. Neuwirth, D. C. Sundstrom and N. H. Thompson: In vitro mechanism of inhibition of bacterial cell growth by allicin. Antimicrob Agents Chemother 32(12), 1763- 1768 (1988).
29. N. Hasan, N. Yusuf, Z. Toossi and N. Islam: Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-α mRNA expression in human monocytes by allicin. FEBS Lett 580(10), 2517-2522 (2006).
30. N. Hasan, M. U. Siddiqui, Z. Toossi, S. Khan, J. Iqbal and N. Islam: Allicin-induced suppression of Mycobacterium tuberculosis 85B mRNA in human monocytes. Biochem Biophys Res Commun 355(2), 471- 476 (2007). (Pubitemid 46282652)
31. G. O'Donnell, R. Poeschl, O. Zimhony, M. Gunaratnam, J. B. C. Moreira, S. Neidle, D. Evangelopoulos, S. Bhakta, J. P. Malkinson, H. I. Boshoff, A. Lenaerts and S. Gibbons: Bioactive Pyridine-N-oxide Disulfides from Allium stipitatum. J Nat Prod 72(3), 360- 365 (2008).
32. C. d. Ledesma: Chocolate: or, and Indian drinke. Translated by James Wandsworth in 1652. Stinson Brand Innovation, London, UK (2009).
33. C. Summa, J. McCourt, B. Cämmerer, A. Fiala, M. Probst, S. Kun, E. Anklam and K.-H. Wagner: Radical scavenging activity, anti-bacterial and mutagenic effects of Cocoa bean Maillard reaction products with degree of roasting. Mol Nutr Food Res 52(3), 342-351 (2008).
34. R. P. Samy, P. N. Pushparaj and P. Gopalakrishnakone: A compilation of bioactive compounds from Ayurveda. Bioinformation 3(3), 100-10 (2008).
35. W. Gao, A. P.-C. Chen, C.-H. Leung, E. A. Gullen, A. Fürstner, Q. Shi, L. Wei, K.-H. Lee and Y.-C. Cheng: Structural analogs of tylophora alkaloids may not be functional analogs. Bioorg Med Chem Lett 18(2), 704-709 (2008).
36. T. Naserpour, A. Mohagheghi, S. Shahraki, M. Naderi and B. Sharafi: Anti-tuberculosis effect of Ocimum sanctum extracts in in vitro and macrophage culture. J Med Sci 6(3), 348-351 (2006).
37. K. P. Sampath, D. Bhowmik, Chiranjib, P. Tiwari and R. Kharel: Indian traditional herbs Adhatoda vasica and its medicinal application. J Chem Pharm Res, 2(1), 240-245 (2010).
38. R. Gupta, B. Thakur, P. Singh, H. B. Singh, V. D. Sharma, V. M. Katoch and S. V. S. Chauhan: Antituberculosis activity of selected medicinal plants against multi-drug resistant Mycobacterium tuberculosis isolates. Indian J Med Res 131, 809-813 (2010).
39. M. Ullah, S. Sultana, A. Haque and S. Tasmin: Antimicrobial, cytotoxic and antioxidant activity of Centella asiatica. Europ J Sci Res 30(2), 260-264 (2009).
40. S. Medda, N. Das, S. B. Mahata, P. R. Mahadevan and M. K. Basu: Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis. Indian J Biochem Biophys 32(3), 147-151 (1995).
41. A. Friis-Møller, M. Chen, K. Fuursted, S. B. Christensen and A. Kharazmi: In Vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med 68(05), 416-419 (2002). (Pubitemid 34606683)
42. V. K. Gupta, A. Fatima, U. Faridi, A. S. Negi, K. Shanker, J. K. Kumar, N. Rahuja, S. Luqman, B. S. Sisodia, D. Saikia, M. P. Darokar and S. P. S. Khanuja: Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharm 116(2), 377-380 (2008).
43. N. Lall and J. J. M. Meyer: In vitro inhibition of drugresistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. J Ethnopharm 66(3), 347-354 (1999). (Pubitemid 29287206)
44. A. C. U. Lourens, A. M. Viljoen and F. R. van Heerden: South African Helichrysum species: A review of the traditional uses, biological activity and phytochemistry. J Ethnopharm 119(3), 630-652 (2008).
45. N. Lall, A. A. Hussein and J. J. M. Meyer: Antiviral and antituberculous activity of Helichrysum melanacme constituents. Fitoterapia 77(3), 230-232 (2006).
46. Meyer, J. J. M., Lall, N., Mathekga and A. D. M.: In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by Helichrysum caespititium. Foundation for Education, Science and Technology, Pretoria, South Africa (2002).
47. L. J. McGaw, N. Lall, J. J. M. Meyer and J. N. Eloff: The potential of South African plants against Mycobacterium infections. J Ethnopharm 119(3), 482-500 (2008).
48. M. S. Rajab, C. L. Cantrell, S. G. Franzblau and N. H. Fischer: Antimycobacterial activity of (E)-phytol and derivatives: A preliminary structure-activity study. Planta Med 64(01), 2-4 (1998). (Pubitemid 28059987)
49. G. Chaudhary, S. Goyal and P. Poonia: Lawsonia inermis Linnaeus: a phytopharmacological review. Int J Pharm Sci Drug Res 2(2), 91-98 (2010).
50. V. K. Sharma: Tuberculostatic activity of henna (Lawsonia inermis Linn.). Tubercle 71(4), 293-295 (1990).
51. C. Courreges, L. Rajabi and T. Primm: Drug development against mycobacteria. University of Texas. Department of Biological Sciences. El Paso, Texas, USA (2003).
52. L. B. Kan: Introduction to Chinese medical literature. Bull Med Libr Assoc 53, 60-70 (1965).
53. Y. Xingrong, F. Bingyi, S. Fang, Q. Jinlin, L. Quan, W. Shuqian, H. Werner, C. Yinfu and Z. Xinsheng: Encyclopedic reference of traditional Chinese medicine. Springer-Verlag, Heidelberg, Germany (2003).
54. D. Lechner, M. Stavri, M. Oluwatuyi, R. Pereda- Miranda and S. Gibbons: The anti-staphylococcal activity of Angelica dahurica (Bai Zhi). Phytochemistry 65(3), 331- 335 (2004). (Pubitemid 38147346)
55. L. Meot-Duros, S. Cérantola, H. Talarmin, C. Le Meur, G. Le Floch and C. Magné: New antibacterial and cytotoxic activities of falcarindiol isolated in Crithmum maritimum L. leaf extract. Food Chem Toxicol 48(2), 553-557 (2010).
56. J. F. Young, L. P. Christensen, P. K. Theil and N. Oksbjerg: The polyacetylenes falcarinol and falcarindiol affect stress responses in myotube cultures in a biphasic manner. Dose-Response 6(3), 239-51 (2008).
57. T. Ohnuma, T. Komatsu, S. Nakayama, T. Nishiyama, K. Ogura and A. Hiratsuka: Induction of antioxidant and phase 2 drug-metabolizing enzymes by falcarindiol isolated from Notopterygium incisum extract, which activates the Nrf2/ARE pathway, leads to cytoprotection against oxidative and electrophilic stress. Arch Biochem Biophys 488(1), 34-41 (2009).
58. J. Chen and T. Chen: Heat clearing herbs Huang Lian. In: Chinese medical herbology and pharmacology. AOM Press. (2004).
59. E. J. Gentry, H. B. Jampani, A. Keshavarz-Shokri, M. D. Morton, D. Vander Velde, H. Telikepalli, L. A. Mitscher, R. Shawar, D. Humble and W. Baker: Antitubercular natural products: Berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, β- hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. J Nat Prod 61(10), 1187-1193 (1998). (Pubitemid 28513340)
60. K. Yoshio, I. Akihiro, F. Mitsuru, F. Haruo, N. Chiaki and K. Nomoto: Activation of peritoneal macrophages by berberine-type alkaloids in terms of induction of cytostatic activity. Int J Immunopharmacol 6(6), 587-592 (1984).
61. G. S. Kumar, D. Debnath, A. Sen and M. Maiti: Thermodynamics of the interaction of berberine with DNA. Biochem Pharmacol 46(9), 1665-1667 (1993). (Pubitemid 23338502)
62. D. Sun, S. N. Abraham and E. H. Beachey: Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother 32(8), 1274-1277 (1988).
63. S. Mahadevan: The legend of Louis Pasteur. Resonance 12(1), 15-22 (2007).
64. R. Brand: Biographical sketch: Baron Joseph Lister, FRCS, 1827-1912. Clin Orthop Relat Res 468(8), 2009- 2011 (2010).
65. B. Lister: The classic: On the antiseptic principle in the practice of surgery. Clin Orthop Relat Res 468(8), 2012- 2016 (2010).
66. S. A. Waksman: What Is an antibiotic or an antibiotic substance? Mycologia 39(5), 565-569 (1947).
67. F. Ryan: Tuberculosis: the greatest story never told. Swift Publishers, Worcestershire, UK (1992).
68. S. H. E. Kaufmann: Paul Ehrlich: founder of chemotherapy. Nat Rev Drug Discov 7(5), 373-373 (2008).
69. D. S. Barnes: Historical perspectives on the etiology of tuberculosis. Elsevier, Kidlington, UK (2000).
70. J. Tyagi: The timeless legacy of Robert Koch. Resonance 11(9), 20-28 (2006).
71. L. Landouzy: The cinquantenary of the experimental demonstration, at the académie de médecine by A. Villemin, of the specific and contagious virulence of tuberculosis. Dublin J Med Sci 141(3), 193-202 (1916).
72. D. S. Burke: Of postulates and peccadilloes: Robert Koch and vaccine (tuberculin) therapy for tuberculosis. Vaccine 11(8), 795-804 (1993). (Pubitemid 23180236)
73. F. Bosch and L. Rosich: The contributions of Paul Ehrlich to pharmacology: A tribute on the occasion of the centenary of his Nobel prize. Pharmacology 82(3), 171-179 (2008).
74. K. Brown: Penicillin man. Alexander Fleming and the antibiotic revolution. Sutton Publishing, Gloucestershire, UK (2004).
75. F. Jones and S. Ricke: Observations on the history of the development of antimicrobials and their use in poultry feeds. Poult Sci 82(4), 613-617 (2003). (Pubitemid 38641937)
76. R. J. Dubos, R. D. Hotchkiss and A. F. Coburn: The effect of gramicin and tyrocidine on bacterial metabolism. J Biol Chem 146(2), 421-426 (1942).
77. L. Fattorini, G. Orefici, S. H. Jin, G. Scardaci, G. Amicosante, N. Franceschini and I. Chopra: Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother 36(5), 1068-1072 (1992).
78. H. H. Kwon, H. Tomioka and H. Saito: Distribution and characterization of [beta]-lactamases of mycobacteria and related organisms. Tuber Lung Dis 76(2), 141-148 (1995).
79. Utrup, L. J., Moore, T. D., Actor, P., Poupard, J. A.: Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents. Antimicrob Agents Chemother 39(7), 1454-1457 (1995).
80. I. Dinçer, A. Ergin and T. Kocagöz: The vitro efficacy of β-lactam and β-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. Int J Antimicrob Agents 23(4), 408-411 (2004). (Pubitemid 38481557)
81. J.-E. Hugonnet and J. S. Blanchard: Irreversible inhibition of the Mycobacterium tuberculosis β-lactamase by clavulanate. Biochemistry 46(43), 11998-12004 (2007). (Pubitemid 350022357)
82. A. R. Flores, L. M. Parsons and Pavelka, Martin S. Jr: Genetic analysis of the β-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to β-lactam antibiotics. Microbiology 151(2), 521-532 (2005). (Pubitemid 40277755)
83. W. Kingston: Streptomycin, Schatz v. Waksman, and the balance of credit for discovery. J Hist Med Allied Sci 59(3), 441-462 (2004). (Pubitemid 41319465)
84. J. Crofton: The MRC randomized trial of streptomycin and its legacy: a view from the clinical front line. J Roy Soc Med 99(10), 531-4 (2006). (Pubitemid 44690269)
85. A. Meier, P. Sander, K. Schaper, M. Scholz and E. Bottger: Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 40(11), 2452-2454 (1996). (Pubitemid 26367624)
86. D. A. Mitchison: The segregation of streptomycin-resistant variants of Mycobacterium tuberculosis into groups with characteristic levels of resistance. J Gen Microbiol 5(3), 596- 604 (1951).
87. B. Springer, Y. G. Kidan, T. Prammananan, K. Ellrott, E. C. Bottger and P. Sander: Mechanisms of streptomycin resistance: Selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob Agents Chemother 45(10), 2877-2884 (2001). (Pubitemid 32906686)
88. F. Bernheim: The effect of salicylate on the oxygen uptake of the tubercle bacillus. Science 92(2383), 204 (1940).
89. A. K. Saz and F. Bernheim: The effect of 2, 3, 5, triiodobenzoate and various other compounds ont he growth of tubercle bacillus. J Pharmacol Exp Ther 73(1), 78-84 (1941).
90. P. B. Woolley: The use of antrenyl in gastro-intestinal irritation due to PAS compounds. Brit J Tuber Dis Chest 51(4), 382-384 (1957).
91. J. Kumazawa and M. Yagisawa: The history of antibiotics: The Japanese story. J Infect Chemother 8(2), 125-133 (2002). (Pubitemid 34839311)
92. H. Umezawa: Kanamycin: its discovery. Ann N Y Acad Sci 76 (The Basic and Clinical Research of the New Antibiotic, Kanamycin), 20-26 (1958).
93. TBAlliance: Kanamycin. Tuberculosis 88(2), 117-118 (2008).
94. Y. Suzuki, C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi and H. Taniguchi: Detection of kanamycinresistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 36(5), 1220-1225 (1998). (Pubitemid 28208002)
95. E. J. Begg and M. L. Barclay: Aminoglycosides - 50 years on. Br J Clin Pharmac 39(6), 597-603 (1995).
96. H. Kawaguchi: Discovery, chemistry, and activity of amikacin. J Infect Dis 134, Supplement, 242-248 (1976).
97. TBAlliance: Amikacin. Tuberculosis 88(2), 87-88 (2008).
98. L. Jugheli, N. Bzekalava, P. de Rijk, K. Fissette, F. Portaels and L. Rigouts: High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 53(12), 5064-5068 (2009).
99. W. McDermott: The story of INH. J Infect Dis 119(6), 678-83 (1969).
100. M. F. Murray: Nicotinamide: An oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin Infect Dis 36(4), 453-460 (2003). (Pubitemid 36241311)
101. J. A. Aeschlimann: Isoniazid - victim of a limited market. Ind Eng Chem 52(1), 22-23 (1960).
102. Y. Zhang, S. Dhandayuthapani and V. Deretic: Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. Proc Natl Acad Sci U S A 93(23), 13212-13216 (1996). (Pubitemid 26382795)
103. C. Vilchèze and J. W. Jr.: The mechanism of isoniazid killing: clarity through the scope of genetics. Ann Rev Microbiol 61(1), 35-50 (2007). (Pubitemid 350058198)
104. D. Lechner, S. Gibbons and F. Bucar: Modulation of isoniazid susceptibility by flavonoids in Mycobacterium. Phytochem Lett 1(2), 71-75 (2008).
105. TBAlliance: Cycloserine. Tuberculosis 88(2), 100-101 (2008).
106. J. Simeon, M. Fink, T. M. Itil and D. Ponce: d- Cycloserine therapy of psychosis by symptom provocation. Compr Psychiatry 11(1), 80-88 (1970).
107. D. H. Kim, W. J. Lees, K. E. Kempsell, W. S. Lane, K. Duncan and C. T. Walsh: Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry 35(15), 4923-4928 (1996).
108. M. Rieber, T. Imaeda and I. M. Cesari: Bacitracin action on membranes of mycobacteria. J Gen Microbiol 55(1), 155-159 (1969).
109. F. Drabløs, D. G. Nicholson and M. Rønning: EXAFS study of zinc coordination in bacitracin A. Biochem Biophys Acta 1431(2), 433-442 (1999). (Pubitemid 29231996)
110. S. Scheindlin: The fight against tuberculosis. Mol Intervent 6(3), 124-130 (2006).
111. P. Sensi: History development of rifampin. Rev Infect Dis 5(3), S402 (1983).
112. W. Wehrli and M. Staehelin: Actions of the rifamycins. Bacteriol Rev 35(3), 290-309 (1971).
113. E. A. Campbell, N. Korzheva, A. Mustaev, K. Murakami, S. Nair, A. Goldfarb and S. A. Darst: Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104(6), 901-912 (2001). (Pubitemid 32289282)
114. TBAlliance: Rifampin. Tuberculosis 88(2), 151-154 (2008).
115. D. L. Williams, L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. J. Gangadharam and T. P. Gillis: Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42(7), 1853-1857 (1998). (Pubitemid 28311593)
116. E. B. Herr and M. O. Redstone: Chemical and physical characterization of capreomycin. Ann N Y Acad Sci 135, 940-946 (1966).
117. S. Nomoto, T. Teshima, T. Wakamiya and T. Shiba: The revised structure of capreomycin. J Antibio 30(11), 955-959 (1977). (Pubitemid 8243961)
118. TBAlliance: Capreomycin. Tuberculosis, 88(2), 89-91 (2008).
119. L. Heifets, J. Simon and V. Pham: Capreomycin is active against non-replicating M. tuberculosis. Ann Clin Microbiol Antimicrob 4(1), 6 (2005).
120. L. M. Fu and T. M. Shinnick: Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips. J Infect 54(3), 277-284 (2007)
121. C. E. Maus, B. B. Plikaytis and T. M. Shinnick: Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(2), 571-577 (2005) (Pubitemid 40175664)
122. G. Di Perri and S. Bonora: Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother 54(3), 593-602 (2004). (Pubitemid 39263899)
123. R. Provvedi, F. Boldrin, F. Falciani, G. Palu and R. Manganelli: Global transcriptional response to vancomycin in Mycobacterium tuberculosis. Microbiology 155(4), 1093-1102 (2009).
124. V. S. Malik: Plasmid and chloramphenicol production in Streptomyces venezuelae. Biotechnol Lett 2(10), 455-457 (1980).
125. L. Katz and G. W. Ashley: Translation and protein synthesis: Macrolides. Chem Rev 105(2), 499-528 (2005).
126. Z. Ma and P. A. Nemoto: Discovery and development of ketolides as a new generation of macrolide antimicrobial agents. Curr Med Chem - Anti-Infect Agents 1, 15-34 (2002).
127. Gasc, J.-C., D'ambrieres, S. G., Lutz, A., Chantot, J.-F.: New ether oxime derivatives of erythromycin A a structure-activity relationship study. J Antibio 44(3), 313- 330 (1991).
128. TBAlliance: Clarithromycin. Tuberculosis 88(2), 92- 95 (2008).
129. C. Truffot-Pernot, N. Lounis, J. Grosset and B. Ji: Clarithromycin is inactive against Mycobacterium tuberculosis. Antimicrob Agents Chemother 39(12), 2827- 2828 (1995).
130. F. Portaels, H. Traore, K. De Ridder and W. M. Meyers: In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother 42(8), 2070-3 (1998). (Pubitemid 28363095)
131. K. Falzari, Z. Zhu, D. Pan, H. Liu, P. Hongmanee and S. G. Franzblau: In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(4), 1447-1454 (2005). (Pubitemid 40463375)
132. J. Z. Zhaohai, K. Olga, P. Dahua, P. Valentina, Y. Gengli, L. Yinghui, L. Huiwen, H. Saweon, W. Yuehong, W. Baojie, L. Wenzhong and G. F. Scott: Structure-activity relationships of macrolides against Mycobacterium tuberculosis. Tuberculosis 88, S49-S63 (2008).
133. T. Noto, S. Miyakawa, H. Oishi, H. Endo and H. Okazaki: Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity. J Antibio 35(4), 401-410 (1982). (Pubitemid 12046394)
134. L. Kremer, J. D. Douglas, A. R. Baulard, C. Morehouse, M. R. Guy, D. Alland, L. G. Dover, J. H. Lakey, W. R. Jacobs, P. J. Brennan, D. E. Minnikin and G. S. Besra: Thiolactomycin and related analogues as novel antimycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem 275(22), 16857-16864 (2000). (Pubitemid 30398921)
135. N. M. Parrish, F. P. Kuhajda, H. S. Heine, W. R. Bishai and J. D. Dick: Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. J Antimicrob Chemother 43(2), 219-226 (1999). (Pubitemid 29082446)
136. S. B. Singh, H. Jayasuriya, J. G. Ondeyka, K. B. Herath, C. Zhang, D. L. Zink, N. N. Tsou, R. G. Ball, A. Basilio, O. Genilloud, M. T. Diez, F. Vicente, F. Pelaez, K. Young and J. Wang: Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J Am Chem Soc 128(36), 11916-11920 (2006). (Pubitemid 44360228)
137. S. B. Singh, K. B. Herath, J. Wang, N. Tsou and R. G. Ball: Chemistry of platensimycin. Tetrahedron Lett 48(31), 5429-5433 (2007). (Pubitemid 47016608)
138. A. K. Brown, R. C. Taylor, A. Bhatt, K. Fütterer and G. S. Besra: Platensimycin activity against mycobacterial β-ketoacyl-ACP synthases. PLoS ONE 4(7), e6306 (2009).
139. G. F. Pauli, R. J. Case, T. Inui, Y. Wang, S. Cho, N. H. Fischer and S. G. Franzblau: New perspectives on natural products in TB drug research. Life Sci 78(5), 485- 494 (2005). (Pubitemid 41653498)
140. I. Orme: Search for new drugs for treatment of tuberculosis. Antimicrob Agents Chemother 45(7), 1943- 1946 (2001). (Pubitemid 32591680)
141. M. J. Hearn and M. H. Cynamon: Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base. J Antimicrob Chemother 53(2), 185-191 (2004). (Pubitemid 38239948)
142. Cantrell, C. L., Franzblau, S. G., Fischer, N. H.: Antimycobacterial plant terpenoids. Planta Med 67(8), 685-694 (2001). (Pubitemid 33044471)
143. G. M. König, A. D. Wright and S. G. Franzblau: Assessment of antimycobacterial activity of a series of mainly marine derived natural products. Planta Med 66(04), 337-342 (2000). (Pubitemid 30346297)
144. N. Kishore, B. B. Mishra, V. Tripathi and V. K. Tiwari: Alkaloids as potential anti-tubercular agents. Fitoterapia 80(3), 149-163 (2009).
145. S. M. Newton, C. Lau and C. W. Wright: A review of antimycobacterial natural products. Phytother Res 14(5), 303-322 (2000). (Pubitemid 30655514)
146. B. R. Copp: Antimycobacterial natural products. Nat Prod Rep 20(6), 535-557 (2003). (Pubitemid 38024760)
147. B. R. Copp and A. N. Pearce: Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 24(2), 278-297 (2007). (Pubitemid 46496562)
148. A. S. Negi, J. K. Kumar, S. Luqman, D. Saikia and S. P. S. Khanuja: Antitubercular potential of plants: A brief account of some important molecules. Med Res Rev 30(4), 603-645 (2010).
149. W. L. Beatty, E. R. Rhoades, H.-J. Ullrich, D. Chatterjee, J. E. Heuser and D. G. Russell: Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1(3), 235-247 (2000).
150. D. G. Russell, H. C. Mwandumba and E. E. Rhoades: Mycobacterium and the coat of many lipids. J Cell Biol 158(3), 421-426 (2002). (Pubitemid 34851700)
151. M.-J. Kim, H. C. Wainwright, M. Locketz, L.-G. Bekker, G. B. Walther, C. Dittrich, A. Visser, W. Wang, F.-F. Hsu, U. Wiehart, L. Tsenova, G. Kaplan and D. G. Russell: Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2(7), 258-274 (2010).
152. S. T. Cole, R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead and B. G. Barrell: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685), 537-544 (1998). (Pubitemid 28319235)
153. K. Minami: Bactericidal action of oleic acid for tubercle bacilli: I. quantitative and analytical survey of the action. J Bacteriol 73(3), 338-344 (1957).
154. T. H. Sattler and G. P. Youmans: The effect of "Tween 80, " bovine albumin, glycerol, and glucose on the growth of Mycobacterium tuberculosis var. hominis (H37Rv). J Bacteriol 56(2), 235-43 (1948).
155. E. Kondo and K. Kanai: The relationship between the chemical structure of fatty acids and their mycobactericidal activity. Jpn J Med Sci Biol 30(4), 171-178 (1977). (Pubitemid 8187768)
156. H. Saito, H. Tomioka and T. Yoneyama: Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids. Antimicrob Agents Chemother 26(2), 164-169 (1984). (Pubitemid 14050219)
157. G. R. Hemsworth and I. Kochan: Secretion of antimycobacterial fatty acids by normal and activated macrophages. Infect Immun 19(1), 170-177 (1978). (Pubitemid 8275222)
158. H. Saito and H. Tomioka: Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids. Antimicrob Agents Chemother 32(3), 400-402 (1988).
159. L. A. Sechi, I. Lezcano, N. Nunez, M. Espim, Dupr, I., A. Pinna, P. Molicotti, G. Fadda and S. Zanetti: Antibacterial activity of ozonized sunflower oil (Oleozon). J Appl Microbiol 90, 279-284 (2001). (Pubitemid 32158748)
160. N. M. Carballeira and M. Pagán: New methoxylated fatty acids from the Caribbean sponge Callyspongia fallax. Journal of Natural Products, 64(5), 620-623 (2001). (Pubitemid 32488680)
161. N. Carballeira, H. Cruz, C. Kwong, B. Wan and S. Franzblau: 2-Methoxylated fatty acids in marine sponges: Defense mechanism against mycobacteria? Lipids 39(7), 675-680 (2004). (Pubitemid 39488886)
162. N. M. Carballeira: New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog Lipid Res 47(1), 50-61 (2008). (Pubitemid 350216622)
163. H. R. Morbidoni, C. Vilchèze, L. Kremer, R. Bittman, J. C. Sacchettini and W. R. Jacobs: Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2- alkynoic acids. Chem Biol 13(3), 297-307 (2006).
164. C. Li, D. Lee, T. N. Graf, S. S. Phifer, Y. Nakanishi, S. Riswan, F. M. Setyowati, A. M. Saribi, D. D. Soejarto, N. R. Farnsworth, I. I. I. J. O. Falkinham, D. J. Kroll, A. D. Kinghorn, M. C. Wani and N. H. Oberlies: Bioactive constituents of the stem bark of Mitrephora glabra. J Nat Prod 72(11), 1949-1953 (2009).
165. M. Herrmann, B. Böhlendorf, H. Irschik, H. Reichenbach and G. Höfle: Maracin and maracen: New types of ethynyl vinyl ether and α-chloro divinyl ether antibiotics from Sorangium cellulosum with specific activity against mycobacteria. Angew Chem Int Ed 37(9), 1253-1255 (1998). (Pubitemid 28259522)
166. C. Ma, R. J. Case, Y. Wang, H.-J. Zhang, G. T. Tan, N. Van Hung, N. M. Cuong, S. G. Franzblau, D. D. Soejarto, H. H. S. Fong and G. F. Pauli: Anti-tuberculosis constituents from the stem bark of Micromelum hirsutum. Planta Med 71(03), 261-267 (2005). (Pubitemid 40476784)
167. H. Yuan, R. He, B. Wan, Y. Wang, G. F. Pauli, S. G. Franzblau and A. P. Kozikowski: Modification of the side chain of micromolide, an anti-tuberculosis natural product. Bioorg Med Chem Lett 18(19), 5311-5315 (2008).
168. C. L. Cantrell, T. Lu, F. R. Fronczek, N. H. Fischer, L. B. Adams and S. G. Franzblau: Antimycobacterial cycloartanes from Borrichia frutescens. J Nat Prod 59(12), 1131-1136 (1996). (Pubitemid 27026572)
169. C. L. Cantrell, M. S. Rajab, S. G. Franzblau and N. H. Fischer: Antimycobacterial triterpenes from Melia volkensii. J Nat Prod 62(4), 546-548 (1999). (Pubitemid 29200730)
170. C. L. Cantrell, M. S. Rajab, S. G. Franzblau, F. R. Fronczek and N. H. Fischer: Antimycobacterial ergosterol-5, 8- endoperoxide from Ajuga remota. Planta Med 65(08), 732- 734 (1999).
171. X. Wei, A. D. Rodríguez, Y. Wang and S. G. Franzblau: Novel ring B abeo-sterols as growth inhibitors of Mycobacterium tuberculosis isolated from a Caribbean Sea sponge, Svenzea zeai. Tetrahedron Lett 48(50), 8851-8854 (2007). (Pubitemid 350103714)
172. T. Akihisa, S. G. Franzblau, M. Ukiya, H. Okuda, F. Zhang, K. Yasukawa, T. Suzuki and Y. Kimura: Antitubercular activity of triterpenoids from Asteraceae flowers. Biol Pharm Bull 28(1), 158-160 (2005). (Pubitemid 40879803)
173. G. A. Wächter, S. G. Franzblau, G. Montenegro, J. J. Hoffmann, W. M. Maiese and B. N. Timmermann: Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens. J Nat Prod 64(11), 1463-1464 (2001). (Pubitemid 33116694)
174. M.-T. Gutierrez-Lugo, Y. Wang, S. G. Franzblau, E. Suarez and B. N. Timmermann: Antitubercular sterols from Thalia multiflora Horkel ex Koernicke. Phytother Res 19(10), 876-880 (2005). (Pubitemid 41665956)
175. R. Rojas, L. Caviedes, J. C. Aponte, A. J. Vaisberg, W. H. Lewis, G. Lamas, C. Sarasara, R. H. Gilman and G. B. Hammond: Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. J Nat Prod 69(5), 845-846 (2006). (Pubitemid 44021421)
176. G. M. Woldemichael, S. G. Franzblau, F. Zhang, Y. Wang and B. N. Timmermann: Inhibitory effect of sterols from Ruprechtia triflora and diterpenes from Calceolaria pinnifolia on the growth of Mycobacterium tuberculosis. Planta Med 69(07), 628-631 (2003). (Pubitemid 37041058)
177. A. M. Janssen, J. J. C. Scheffer and A. B. Svendsen: Antimicrobial activities of essential oils. Pharm World Sci 9(4), 193-197 (1987).
178. A. Woolf: Essential oil poisoning. Clin Toxicol 37(6), 721-727 (1999).
179. R. Singh, O. Koul, P. J. Rup and J. Jindal: Toxicity of some essential oil constituents and their binary mixtures against Chilo partellus (Lepidoptera: Pyralidae). Int J Trop Insect Sci 29(02), 93-101 (2009).
180. J. G. Bueno-Sanchez, J. R. Martínez-Morales, E. E. Stashenko and W. Ribon: Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia. Biomédica 29, 51-60 (2009).
181. N. H. Fischer, T. Lu, C. L. Cantrell, J. Castaneda-Acosta, L. Quijano and S. G. Franzblau: Antimycobacterial evaluation of germacranolides Phytochemistry, 49(2), 559-564 (1998). (Pubitemid 28415134)
182. T. S. Tiuman, T. Ueda-Nakamura, D. A. Garcia Cortez, B. P. Dias Filho, J. A. Morgado-Diaz, W. de Souza and C. V. Nakamura: Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother 49(1), 176-182 (2005). (Pubitemid 40065790)
183. C. L. Cantrell, I. S. Nuñez, J. Castañeda-Acosta, M. Foroozesh, F. R. Fronczek, N. H. Fischer and S. G. Franzblau: Antimycobacterial activities of dehydrocostus lactone and its oxidation products. J Nat Prod 61(10), 1181-1186 (1998). (Pubitemid 28513339)
184. C.-M. Sun, W. Jr.Syu, M.-J. Don, J.-J. Lu and G.-H. Lee: Cytotoxic sesquiterpene lactones from the root of Saussurea lappa. J Nat Prod 66(9), 1175-1180 (2003). (Pubitemid 37204214)
185. V. E. Madikane, S. Bhakta, A. J. Russell, W. E. Campbell, T. D. W. Claridge, B. G. Elisha, S. G. Davies, P. Smith and E. Sim: Inhibition of mycobacterial arylamine Nacetyltransferase contributes to antimycobacterial activity of Warburgia salutaris. Bioorg Med Chem 15(10), 3579-3586 (2007). (Pubitemid 46546632)
186. A. Ulubelen, G. Topcu and C. B. Johansson: Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity. J Nat Prod 60(12), 1275-1280 (1997). (Pubitemid 28030250)
187. G. Topçu, R. Erenler, O. Çakmak, C. B. Johansson, C. Çelik, H.-B. Chai and J. M. Pezzuto: Diterpenes from the berries of Juniperus excelsa. Phytochemistry 50(7), 1195- 1199 (1999). (Pubitemid 29198074)
188. K. Dimas, M. Papadaki, C. Tsimplouli, S. Hatziantoniou, K. Alevizopoulos, P. Pantazis and C. Demetzos: Labd-14-ene- 8, 13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs. Biomed Pharmacother 60(3), 127-133 (2006).
189. L. J. McGaw, N. Lall, T. M. Hlokwe, A. L. Michel, J. J. M. Meyer and J. N. Eloff: Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria. Biol Pharm Bull 31(7), 1429-1433 (2008). (Pubitemid 351930662)
190. J. L. d. Silva, A. R. Mesquita and E. A. Ximenes: In vitro synergic effect of γ-lapachone and isoniazid on the growth of Mycobacterium fortuitum and Mycobacterium smegmatis. Mem Inst Oswaldo Cruz 104, 580-582 (2009).
191. V. Kuete, J. G. Tangmouo, J. J. Marion Meyer and N. Lall: Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. Int J Antimicrob Agents 34(4), 322-325 (2009).
192. A. Mahapatra, S. P. N. Mativandlela, B. Binneman, P. B. Fourie, C. J. Hamilton, J. J. M. Meyer, F. van der Kooy, P. Houghton and N. Lall: Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase. Bioorg Med Chem 15(24), 7638-7646 (2007). (Pubitemid 47592889)
193. D. Sareen, G. L. Newton, R. C. Fahey and N. A. Buchmeier: Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman. J Bacteriol 185(22), 6736-6740 (2003). (Pubitemid 37385898)
194. N. A. Buchmeier, G. L. Newton and R. C. Fahey: A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress. J Bacteriol 188(17), 6245-6252 (2006). (Pubitemid 44448566)
195. M. Rawat and Y. Av-Gay: Mycothiol-dependent proteins in actinomycetes. FEMS Microbiol Rev 31, 278-292 (2007). (Pubitemid 46540312)
196. R. Mathew, A. K. Kruthiventi, J. V. Prasad, S. P. Kumar, G. Srinu and D. Chatterji: Inhibition of mycobacterial growth by plumbagin derivatives. Chem Biol Drug Des 76(1), 34-42 (2010).
197. S. B. Ferreira, F. d. C. d. Silva, F. A. F. M. Bezerra, M. C. S. Lourenço, C. R. Kaiser, A. C. Pinto and V. F. Ferreira: Synthesis of α- and β-pyran naphthoquinones as a new class of antitubercular agents. Arch Pharm 343(2), 81- 90 (2010).
198. P. Rijo, M. F. Simões, A. P. Francisco, R. Rojas, Robert H. Gilman, Abraham J. Vaisberg, B. Rodríguez and C. Moiteiro: Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains. Chem Biodivers 7(4), 922-932 (2010).
199. W.-Y. Lin, C.-F. Peng, I.-L. Tsai, J.-J. Chen, M.-J. Cheng and I.-S. Chen: Antitubercular constituents from the roots of Engelhardia roxburghiana. Planta Med 71(02), 171-175 (2005). (Pubitemid 40363562)
200. C.-C. Wu, C.-F. Peng, I.-L. Tsai, M. H. Abd El-Razek, H.-S. Huang and I.-S. Chen: Secondary metabolites from the roots of Engelhardia roxburghiana and their antitubercular activities. Phytochemistry 68(9), 1338-1343 (2007). (Pubitemid 46602455)
201. A. M. Galal: Antimicrobial activity of 6-paradol and related compounds. Pharm Biol 34(1), 64-69 (1996).
202. S. M. Newton, C. Lau, S. S. Gurcha, G. S. Besra and C. W. Wright: The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. J Ethnopharm 79(1), 57-67 (2002). (Pubitemid 34017241)
203. C.-Z. Wu, S. S. Hong, X. F. Cai, N. T. Dat, J.-X. Nan, B. Y. Hwang, J. J. Lee and D. Lee: Hypoxia-inducible factor-1 and nuclear factor-[kappa]B inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia. Bioorg Med Chem Lett 18(8), 2619-2623 (2008). (Pubitemid 351503880)
204. H. Jayasuriya, A. M. Clark and J. D. McChesney: New antimicrobial filicinic acid derivatives from Hypericum drummondii. J Nat Prod 54(5), 1314-1320 (1991).
205. H. Jayasuriya, J. D. McChesney, S. M. Swanson and J. M. Pezzuto: Antimicrobial and cytotoxic activity of rottlerintype compounds from Hypericum drummondii. J Nat Prod 52(2), 325-331 (1989). (Pubitemid 19119265)
206. P. Seephonkai, M. Isaka, P. Kittakoop, P. Palittapongarnpim, S. Kamchonwongpaisan, M. Tanticharoen and Y. Thebtaranonth: Evaluation of antimycobacterial, antiplasmodial and cytotoxic activities of preussomerins isolated from the lichenicolous fungus Microsphaeropsis sp. BCC 3050. Planta Med 68(01), 45-48 (2002). (Pubitemid 34113587)
207. A. Schinkovitz, S. Gibbons, M. Stavri, M. J. Cocksedge and F. Bucar: Ostruthin: An antimycobacterial coumarin from the roots of Peucedanum ostruthium. Planta Med 69(04), 369- 371 (2003). (Pubitemid 36578006)
208. J. I. Kobayash, J.-F. Cheng, H. Nakamura, Y. Ohizumi, Y. Hirata, T. Sasaki, T. Ohta and S. Nozoe: Ascididemin, a novel pentacyclic aromatic alkaloid with potent antileukemic activity from the okinawan tunicate sp. Tetrahedron Lett 29(10), 1177-1180 (1988). (Pubitemid 18071146)
209. B. R. Copp, H. C. Christiansen, B. S. Lindsay and S. G. Franzblau: Identification of heteroarylenamines as a new class of antituberculosis lead molecules. Bioorg Med Chem Lett 15(18), 4097-4099 (2005). (Pubitemid 41132668)
210. H. I. M. Boshoff, T. G. Myers, B. R. Copp, M. R. McNeil, M. A. Wilson and C. E. Barry: The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem 279(38), 40174-40184 (2004).
211. J. U. M. Rao, G. S. Giri, T. Hanumaiah and K. V. J. Rao: Sampangine, a new alkaloid from Cananga odorata. J Nat Prod 49(2), 346-347 (1986). (Pubitemid 16068776)
212. K. Y. Orabi: Microbial models of mammalian metabolism. Sampangines. Stud Nat Prod Chem 23, 3-49 (2000).
213. I. Muhammad, D. C. Dunbar, S. Takamatsu, L. A. Walker and A. M. Clark: Antimalarial, cytotoxic, and antifungal alkaloids from Duguetia hadrantha. J Nat Prod 64(5), 559-562 (2001). (Pubitemid 32488667)
214. M. Adams, A. A. Wube, F. Bucar, R. Bauer, O. Kunert and E. Haslinger: Quinolone alkaloids from Evodia rutaecarpa: a potent new group of antimycobacterial compounds. Int J Antimicrob Agents 26(3), 262-264 (2005). (Pubitemid 41219616)
215. J. D. Guzman, A. Gupta, D. Evangelopoulos, C. Basavannacharya, L. C. Pabon, E. A. Plazas, D. R. Muñoz, W. A. Delgado, L. E. Cuca, W. Ribon, S. Gibbons and S. Bhakta: Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. J Antimicrob Chemother 65(10), 2101-2107 (2010).
216. M. Isaka, N. Rugseree, P. Maithip, P. Kongsaeree, S. Prabpai and Y. Thebtaranonth: Hirsutellones A-E, antimycobacterial alkaloids from the insect pathogenic fungus Hirsutella nivea BCC 2594. Tetrahedron 61(23), 5577-5583 (2005). (Pubitemid 40712280)
217. K. V. Rao, N. Kasanah, S. Wahyuono, B. L. Tekwani, R. F. Schinazi and M. T. Hamann: Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases. J Nat Prod 67(8), 1314-1318 (2004). (Pubitemid 39145636)